Fibrosis and angiogenesis are the most common processes that result in progressive peritoneal tissue remodeling and, eventually, peritoneal membrane dysfunction. The role of exosomes, which contributes to intercellular communication, in these processes has been neglected. Various biomolecules, including DNA, mRNA, proteins, lipids, and particular certain miRNAs, can be transferred by exosomes to local, neighboring and distal cells. Upon stimulation by cytokines or other microenvironment stimuli, donor cells release a mass of exosomes to peritoneal mesothelial cells, further affecting fibrosis and angiogenesis. This important exosomes-mediated intracellular communication is thought to regulate peritoneal membrane function. Understanding the molecular mechanisms of these processes, targeting changes in exosomes and regulating exosomal miRNAs will advance therapeutic methods for protecting peritoneal membrane function.
Introduction
The structure of the peritoneal membrane (PM) is composed of a single layer of highly specialized mesothelial cells that lines a compact zone, which includes few fibroblasts, mast cells, macrophages and blood vessels [1] . This zone also covers an underlying stroma containing extracellular matrix (ECM) and stromal cells [2] . Peritoneal mesothelial cells (PMCs), as active participants, play a significant role in maintaining normal PM function.
Several factors contribute to PM dysfunction, including continuous peritoneal dialysis (PD), tumor with peritoneal metastasis, traumatic surgery, and toxic reagents. The most frequent findings for histomorphological peritoneal problems are submesothelial fibrosis, angiogenesis and hyalinizing vasculopathy [3] . PMCs have been proposed to be the cells primarily responsible for the pathogenesis of PM dysfunction. In PD, after longterm exposure to various glucose degradation products (GDPs) and advance glycation end
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PF has a crucial influence on PM structure and function. The pathogenesis of PF is characterized by a decreasing number of mesothelial cells and progressive submesothelial thickening with an increasing myofibroblast presence [23] . The accumulation of collagenproducing fibroblasts and excessive deposition of ECM disrupt normal peritoneal architecture and homeostasis [24] . During initial phases, epithelial-mesenchymal transition (EMT) plays a central role in the alterations of PMCs, leading to fibrosis. EMT is the stepwise loss of epithelial characteristics and the acquisition of a myofibroblast-like phenotype [25] . This complex pathological process consists of disruption of intercellular junctions, loss of apicalbasolateral polarity, cytoskeletal remodeling and acquisition of migratory and invasive characteristics [26] . Mesothelial-derived myofibroblasts induce the accumulation of ECM proteins and contraction of the repairing tissue, thus prompting fibrosis [27, 28] .
In PD, the use of traditional bio-incompatible PD solutions with high glucose concentrations and GDPs are implicated in PF [29] . Transforming growth factor β1 (TGF-β1) plays a central role in PF through the induction of numerous pro-fibrotic events, including EMT, fibroblast proliferation and ECM deposition [30] . In fact, high glucose PD solutions stimulate TGF-β1 synthesis and TGF-β1-induced PF [31] . Additionally, surgical or accidental injury, as well as viral and bacterial infections, may stimulate and damage PMCs [32] . In these cases, persistent triggers cause fibrosis or scarring, impairing normal PM function [33] . In addition, peritoneal metastasis, which is significantly related to EMT, is another way to promote fibrosis [34] . Metastatic tumors infiltrate structures, contacting the visceral layer of the PM and diffusing into the peritoneal cavity. These cells attach to the mesothelium and generate metastatic PM lesions, accompanied by EMT and fibrosis [35] . In tumor metastasis, cancer cells activate essential genes and signaling pathways related to EMT, including Snail, Twist, zinc finger E-box-binding homeobox 1 (Zeb1), and insulin-like growth factor receptor (IGFR). Recent studies have indicated that IGFR may induce EMT through Snail in mammary epithelial cells and through the up-regulation of Zeb1 and latent TGF-β1 [36] . Recently, epigenetic changes have been implicated in tumor metastasis and EMT. For example, silencing of the TET-mediated demethylation of anti-metastatic miR-200 promotes tumor metastasis [37] .
At later stages, fibrosis occurs significantly more often in the presence of vasculopathy, such as an increased density of peritoneal blood vessels, and with submesothelial and perivascular fibrosis [38] . In PD, the release of angiogenic factors, such as basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), TGF-β1 and epidermal growth factor (EGF), leads to degradation of the vascular basement membrane and activation of endothelial cells [39] . These events are involved in the proliferation and migration of PMCs. As the lesion burden grows, PMCs are recruited to form new blood vessels and promote matrix-remodeling enzymes, improving angiogenesis. PMCs that have undergone EMT increase the potential for invasion and migration into the submesothelial zone, leading to further neovascularization [40] . Inhibiting angiogenesis ameliorates PF [41] . Similarly, metastatic tumor cells express matrix proteinases that disrupt the peritoneal blood barrier and attachment to the PM, enabling invasion into the subperitoneal space and proliferation in response to angiogenesis. Subsequently, angiogenesis is crucial for progressive PM lesions [42] .
In summary, fibrosis and angiogenesis affect PM lesions during different stages, synergistically mediating PM function.
The potential relevance between exosomes and PMCs
Exosomes have buoyant density and are formed from the luminal membrane of endosomal multivesicular bodies. Endosomal multivesicular bodies are always targeted for the plasma membrane and release exosomes into the extracellular environment [43, 44] . Exosomes harbor organelle-like lipid-bound membranous structures derived from most cell types. They provide an important molecular mechanism through which cells can affect local, neighboring, and distant cells and their environments [45] . Previous studies illuminated the exosomes-mediated regulation of various biologic functions, including intercellular communication and antigen presentation [46] . Functional exosomes always transfer genetic material from a donor cell to a recipient cell through the incorporation of DNA, mRNA, miRNA, proteins and lipids [47] . For example, during tumor progression, mRNA delivered by exosomes can affect the translational profile of recipient cells [48] . Thakur and colleagues indicated that mutated KRAS and p53 in dsDNA within pancreatic cancer cell-derived exosomes are the most frequent mutations in human pancreatic cancer. They suggested that exosomal DNA harbors these mutations and can serve as a biomarker in cancer diagnostics [49] . In another study, TGF-β1 mRNA delivered via exosomes from fibroblasts to epithelial cells initiated an autocrine process, inducing the loss of epithelial function and leading to EMT [50] .
Accumulating evidences showed that epithelial cells, mast cells, fibroblasts and adipocytes can produce increased numbers of exosomes [12, 15, 17, 51, 52] . In fact, the PM consists of three layers, including the mesothelial monolayer and loose adipose tissue. Anatomically, PMCs are crucial components with characteristics similar to those of epithelial cells. The omental or mesenteric peritoneum is composed of an abundant nest of mature adipocytes [53] . All these components are essential for normal PM function. Meanwhile, rich exosomes can be detected in PMCs (recipient cells) due to intercellular deliveries from other types of cell (donor cells). When donor cells are stimulated by cytokines, high glucose, hypoxia and other stimuli, they can produce numerous exosomes and subsequently transfer these exosomes to PMCs [54] . This cell-to-cell communication alters the function and phenotype of PMCs [55] . Therefore, it is plausible to suggest that a potential relationship between exosomes and PMCs is important.
In addition, several studies have indicated that exosomes derived from cancer cells cause the proliferation and transformation of PMCs [56] . In the process of peritoneal metastasis, normal PMCs become carcinoma-associated fibroblasts. The cancer cells float in the peritoneal cavity and attach to a single layer, invading through the mechanical barrier of PMCs. The underlying ECM turns into the peritoneum, omentum or bowel serosa. Furthermore, the presence of ascites, an accumulation of protein-rich exudate in the peritoneal cavity, accelerates the invasion and migration of PMCs [57] . Importantly, exosomes can be detected in PMCs after incubation with tumor-derived exosomes [54] .
Functional contribution of exosomes in fibrosis and angiogenesis
Exosomes mediate fibrosis and angiogenesis through the regulation of intercellular communication. The activation of fibroblasts is recognized as a critical step in the process of fibrosis [58] . Exosomes, as peritoneal metastatic transplants from donor cells, promote TGF-β1-induced fibrosis by transferring TGF-β1. As the recipient cells, PMCs show increased ability to proliferate, migrate and recruit numerous fibroblasts [59] . Additionally, data from some clinical samples indicated that TGF-β1 may be overexpressed in malignant ascitesderived exosomes, and this high concentration of TGF-β1 is responsible for fibrosis [54] . TGF-β1 mRNA is delivered by exosomes to fibroblasts and in turn translated into protein that initiates an autocrine process, ultimately leading to proliferation, EMT and typeⅠcollagen (COL-1) production in neighboring fibroblasts [50] . Furthermore, exosomes enhance the expression of EMT markers and adhesion molecules via TGF-β1, including α-smooth muscle actin (α-SMA), E-cadherin, fibronectin (FN), laminin gamma-1 (LAMC-1), hyaluronan (HA), and vascular cell adhesion molecule-1 (VCAM-1) [60] . Similarly, after exosomes treatment, the expression of α-SMA, FN, LAMC-1 and HA increased, while the expression of E-cadherin and VCAM-1 decreased. Indeed, TGF-β1 expressed at the exosomes surface can increase factors related to fibroblast-myofibroblast differentiation [61] . Thus, internalized exosomes within PMCs have TGF-β1 as their cargo, facilitating fibroblast activation, promoting the expression of adhesion molecules and the EMT of PMCs, and leading to fibrosis [62] . Briefly, TGF-β1 mRNA transferred by exosomes is functionally important for intercellular communication.
Reducing the release of exosomes and the TGF-β1 mRNA they carry is necessary to inhibit the progression of fibrosis [63] .
In addition, the administration of exosomes significantly mediates angiogenesis [64] . Angiogenesis is triggered by several growth factors and cytokines in the microenvironment [65] . The effect of exosomes on inducing angiogenesis in microenvironment has been demonstrated [66] . Enhanced microvessel density and blood perfusion in ischemic tissues have been confirmed after exosomes treatment [67] . For example, Gonzalez et al. showed that exosomes stably overexpressing hypoxia inducible factor-1α (HIF-1α) exhibit increased angiogenic capacity, in part through an increase in the packaging of Jagged1 [68] . This HIF-1α-based mechanism regulates MSCs-derived exosomes and exosomes-mediated angiogenesis [67] . Both hypoxia and overexpression of HIF-1α can increase exosomes secretion. Also, Kucharzewska et al. presented that exosomes are a potent regulator of hypoxia-dependent intercellular communication between malignant and vascular cells, suggesting a basis for the effect of exosomes during the hypoxia-driven pro-angiogenic response [69] . Moreover, exosomes promote endothelial cells proliferation, migration and tube-like formation. It has been illustrated that exosomes markedly increase endothelial proliferation by incorporating a significant amount of heat shock protein 20 (Hsp20), which activates the VEGF2 signaling pathway in endothelial cells and promotes angiogenesis [70] . Another way of exosomes has been proposed to affect angiogenesis through the mesenchymal-endothelial transition (MEndT). High mobility group box 1 protein B1 (HMGB1) plays a crucial role in angiogenesis, and inhibition of HMGB1 can alleviate vascular dysfunction and remodeling. Indeed, endothelial cell-derived exosomes promote the proliferation and angiogenesis of fibroblasts by inhibiting MEndT and decreasing HMGB1 [71] .
Exosomes affect fibrosis and angiogenesis via exosomal miRNAs
Exosomal miRNAs in fibrosis miRNAs are a major class of small non-coding RNAs that mediate post-transcriptional gene silencing through mRNA destabilization, translational inhibition and mRNA degradation [72] . miRNAs are indispensable for fibrosis, and a large number of miRNA families have been shown to modulate fibrosis [73] . Indeed, miRNAs are incorporated into exosomes, wherein they are more stable than in the cellular compartment. Released miRNAs and their binding exosomes can resist degradation from cells or in circulation in body fluids [74] . This apparent stability underscores the attractiveness of exosomal miRNAs as disease biomarkers. Also, accumulating evidences indicated that miRNAs may serve as a tool for fibrosis disease diagnosis. Abnormal urinary or plasma miRNAs expression in exosomes could be used for patient prognosis [75, 76] . Although multiple mechanisms could play a role in generating a cellular miRNA profile, exosomes-mediated cell-cell exchange of RNA has been described as a determinant of such profiles [45] . miRNAs are packed into exosomes, which can be exchanged between cells without loss of function of the included miRNAs [77] . Most miRNAs confirmed to be related to fibrosis induce or inhibit fibrosis by targeting TGF-β1 pathways or ECM structural proteins. Affecting EMT, inducing myofibroblast proliferation and exerting anti-apoptosis activity in myofibroblasts are other fibrosis regulatory mechanisms.
The miR-181 family of miRNAs has been associated with autophagy that subsequently lowers the level of ECM components [78] . A recent study found that exosomes treatment could attenuate the fibrotic components COL-1, Vimentin, α-SMA, and FN. Exosomal miR-181-5p can be delivered to recipient cells in a fibrosis model and alleviate the level of fibrosis in the tissue. Specifically, miR-181-5p attenuates signal transducer and activator of transcription (STAT3) and B-cell lymphoma-2 (Bcl-2) expression. TGF-β1 induces fibrogenic cytokines through activating STAT3, which further regulates the transcription of Bcl-2. TGF-β1 can also increase Bcl-2 via MAPK/ERK signaling [79] . Thus, increasing the transfer of exosomal miR-181-5p inhibits fibrosis by negatively regulating STAT3 and Bcl-2 gene expression.
The let-7 family of miRNAs is reported to be regulated post-transcriptionally [80] . Reduced expression of let-7 miRNAs has been implicated in EMT and enhanced cell migration. In particular, let-7 enhances fibrosis by affecting the TGF-β1 pathway [81] . The target genes of this family include TGFBR1, Smad2, COL-1A1 and COL-1A2. The release of exosomal let-7 into the extracellular environment has been suggested to attenuate fibrosis [75, 82, 83] . miR-21, miR-378e and miR-143 were shown by Donnarumma and colleagues to exhibit a distinctly increased capacity for EMT. Decreasing exosomal delivery of miR-21, miR-378e and miR-143 can alleviate EMT [84] . Aside from the exosomal miRNAs mentioned above, other miRNAs derived from various cell types affect fibrosis (Table 1) . 
Exosomal miRNAs in angiogenesis
During exosomal transfer, miRNAs may be instrumental in mediating the effects of exosomes on angiogenesis.
HIF-1α is a key regulator in the cellular adaptation to hypoxia and activates various angiogenic factors [97] . Overexpression of HIF-1α in MSCs (HIF-MSCs) can increase the secretion of exosomes and induce angiogenesis. However, miRNAs loaded in HIF-MSCderived exosomes, including miR-15, miR-16, miR-17, miR-31, miR-126, miR-145, miR-221, miR-222, miR-320a and miR-424, have been reported to mediate angiogenesis [98, 99] . The mechanism of these miRNAs on angiogenesis may involve vesicular trafficking and positive regulation of cell communication, thus targeting pathways related to hypoxia or HIF-1α stabilization, such as the Wnt, TGF-β and VEGF pathways [100] . In addition, factor inhibiting hypoxia-inducible factor-1 (FIH-1), an asparaginyl hydroxylase enzyme that binds to HIF-1α, could inhibit the angiogenesis-related transactivation function of HIF-1α. Exosomal miR-135b contributes to angiogenesis by accelerating HIF-1α transcriptional activity via inhibition of FIH-1 [101, 102] .
Intercellular tight junctions of the endothelium are important for the formation of blood vessel barriers [103] . ZO-1, in a regulatory role, affects angiogenesis and endothelial barrier formation [104] . Beyond the regulation of angiogenesis with exosomal miR-23a targeting HIF-1α, it is suggested that miR-23a disrupts the endothelial barrier by targeting ZO-1. Hsu and colleagues elucidated a new mechanism in which exosomal miR-23a increases angiogenesis by the HIF-1α/ZO-1 pathway [105] .
VEGF is another predominant inducer of normal and pathophysiological angiogenesis. Exosomes transferring miRNAs (i.e. miR-16, miR-100, miR-126) may suppress angiogenesis through regulating VEGF signaling, as an increase in exosomes elicits a marked decrease in VEGF and VEGFR-1 transcript levels [106, 107, 108] . Meanwhile, exosomal miRNAs regulate VEGF-related signaling (i.e. mTOR/HIF-1α/VEGF axin). miRNAs shuttled by exosomes take part in the proliferation and angiogenesis of endothelial cells through the mTOR pathway [109] .
In angiogenesis, miR-320 is delivered by exosomes into endothelial cells and mediates anti-angiogenesis functions [19] . The function of exosomal miR-320 in endothelial cells appears to be reducing Hsp20 and IGF-1. IGF-1 positively affects angiogenesis by improving the migration of vascular smooth muscle cells and exerting anti-apoptosis effects [110] . Hsp20 promotes angiogenesis by activating the VEGFR2 pathway [70] .
Exosomal miR-214 is transferred into endothelial cells to aid in vascular repair, neovascularization and regeneration [111] . It has been proven to stimulate angiogenesis through repressing ataxia telangiectasia mutated (ATM) in neighboring recipient cells and affecting the proliferation and differentiation of myoblasts and T cells. ATM increases cellular senescence and targets the HIF-1α pathway to further induce angiogenesis [112] .
Conclusion
Patients in long-term PD or with peritoneal metastasis undergo progressive fibrosis and angiogenesis. The pathological processes of fibrosis and angiogenesis contribute to PM dysfunction. During these processes, exosomes participate in regulating PM function by affecting fibrosis and angiogenesis. Genetic information for fibrotic and angiogenic factors could be transferred by exosomes to recipient cells, further affecting target genes or signaling pathways correlated with fibrosis and angiogenesis (Fig. 1) . This review summarizes recent research progress on exosomes and exosomal miRNAs in fibrosis and angiogenesis, highlighting the role of exosomes in mediating PM function. Exosomes derived from donor cells can deliver TGF-β1 to PMCs and target EMT markers, adhesion molecules and ECM proteins, ultimately affecting fibrosis. Exosomal miR-181, Let-7, miR-26a, miR-200, miR- 
